It was reported that miR-122 and Sirt1 suppressed TGF-β signalling to affect liver cancer metastasis (Yin et al., 2016) and ameliorate renal fibrosis (Huang et al., 2014), respectively. Here, TGFB1 is linked to liver cancer.